A study led by UC San Diego sheds light on why Alzheimer’s drugs so far have been ineffective at curing or reversing the disease. The researchers identify new targets for drug development and present a new method to screen drugs for treating Alzheimer’s disease.
Related Articles

News
Weight for It: Time-Restricted Eating Benefits Those at Risk for Diabetes, Heart Disease
December 5, 2019
sandiegobiotech
News
Comments Off on Weight for It: Time-Restricted Eating Benefits Those at Risk for Diabetes, Heart Disease

News
It Starts from Within
As Lucas Anthony Lima prepares to deliver a message of congratulations to his 7,000 peers as Commencement student speaker, he draws inspiration from the lessons he has instilled in his little brother. The most i… […]

News
UC San Diego Scholar of Eastern Europe Amelia Glaser Selected as Harvard Radcliffe Fellow
July 20, 2021
sandiegobiotech
News
Comments Off on UC San Diego Scholar of Eastern Europe Amelia Glaser Selected as Harvard Radcliffe Fellow
Associate professor Amelia Glaser has been named a 2021–2022 fellow at Harvard Radcliffe Institute, where she will investigate contemporary literature and art in Ukraine to better understand how a collective identity can be publicly reimagined during, and immediately following, political upheaval. Click here to view original post… […]